Barclays Maintains Overweight on Nutanix, Lowers Price Target to $80
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Tim Long maintains an Overweight rating on Nutanix (NASDAQ:NTNX) but lowers the price target from $81 to $80.

May 30, 2024 | 7:28 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Barclays analyst Tim Long maintains an Overweight rating on Nutanix but lowers the price target from $81 to $80.
The Overweight rating suggests a positive outlook, but the slight reduction in the price target indicates a minor adjustment in expectations. This is likely to have a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100